Page last updated: 2024-09-05

sorafenib and Multiple Primary Neoplasms

sorafenib has been researched along with Multiple Primary Neoplasms in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	8 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Coleman, EL; Cowper, SE; Leventhal, JS; Stein, SM	1
Futsukaichi, Y; Kobayashi, S; Minemura, M; Nagata, K; Tajiri, K; Takahara, T; Yasuda, I; Yasumura, S	1
Fan, HK; Fan, J; Gao, Q; Ren, ZG; Xie, DY	1
In, GK; Ricker, C; Snow, A	1
Hargreaves, S; Hull, D; Hussain, SA; Johnson, PJ; Ma, YT; Palmer, DH; Ross, PJ; Smith, AJ	1
Tan-Shalaby, J	1
Casadei Gardini, A; Chiadini, E; Delmonte, A; Dubini, A; Faloppi, L; Frassineti, GL; Loretelli, C; Lucchesi, A; Marisi, G; Oboldi, D; Scartozzi, M; Ulivi, P	1
Arachchi, NJ; Bhullar, A; Bhullar, M	1

Reviews

2 review(s) available for sorafenib and Multiple Primary Neoplasms

Article	Year
Combined hepatocellular-cholangiocarcinoma successfully treated with sorafenib: case report and review of the literature. Clinical journal of gastroenterology, 2019, Volume: 12, Issue:2 Topics: Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Cholangiocarcinoma; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Protein Kinase Inhibitors; Remission Induction; Sorafenib	2019
Identifying Clonal Origin of Multifocal Hepatocellular Carcinoma and Its Clinical Implications. Clinical and translational gastroenterology, 2019, Volume: 10, Issue:2 Topics: Biomarkers, Tumor; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Chromosome Aberrations; Clone Cells; Diagnosis, Differential; Hepatectomy; Hepatitis B virus; High-Throughput Nucleotide Sequencing; Humans; Liver; Liver Neoplasms; Mutation; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Patient Selection; Precision Medicine; Sorafenib; Treatment Outcome; Tumor Suppressor Protein p53	2019

Article

Year

Combined hepatocellular-cholangiocarcinoma successfully treated with sorafenib: case report and review of the literature.

Clinical journal of gastroenterology, 2019, Volume: 12, Issue:2

Topics: Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Cholangiocarcinoma; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Protein Kinase Inhibitors; Remission Induction; Sorafenib

2019

Identifying Clonal Origin of Multifocal Hepatocellular Carcinoma and Its Clinical Implications.

Clinical and translational gastroenterology, 2019, Volume: 10, Issue:2

Topics: Biomarkers, Tumor; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Chromosome Aberrations; Clone Cells; Diagnosis, Differential; Hepatectomy; Hepatitis B virus; High-Throughput Nucleotide Sequencing; Humans; Liver; Liver Neoplasms; Mutation; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Patient Selection; Precision Medicine; Sorafenib; Treatment Outcome; Tumor Suppressor Protein p53

2019

Other Studies

6 other study(ies) available for sorafenib and Multiple Primary Neoplasms

Article	Year
Erythema Nodosum-like Eruption in the Setting of Sorafenib Therapy. JAMA dermatology, 2018, 03-01, Volume: 154, Issue:3 Topics: Adenomatous Polyposis Coli; Aged; Antineoplastic Agents; Duodenal Neoplasms; Erythema Nodosum; Female; Fibroma; Humans; Middle Aged; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Sorafenib	2018
Two synchronous malignancies: nodular melanoma and renal cell carcinoma in a patient with an underlying germline BMJ case reports, 2019, Jun-20, Volume: 12, Issue:6 Topics: BRCA2 Protein; Carcinoma, Renal Cell; Chemoradiotherapy, Adjuvant; Female; Germ-Line Mutation; Humans; Melanoma; Middle Aged; Mutation; Neoplasm Staging; Neoplasms, Multiple Primary; Protein Kinase Inhibitors; Sorafenib; Treatment Outcome	2019
Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom. British journal of cancer, 2013, Aug-20, Volume: 109, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Cohort Studies; Female; Health Care Rationing; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Niacinamide; Phenylurea Compounds; Retrospective Studies; Sorafenib; United Kingdom; Young Adult	2013
Complete radiographic remission with 5-fluorouracil and leucovorin after sorafenib failure in hepatocellular carcinoma: is there a role for chemotherapy after targeted agents? BMJ case reports, 2013, Sep-16, Volume: 2013 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Fatal Outcome; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Niacinamide; Phenylurea Compounds; Sorafenib; Tomography, X-Ray Computed; Treatment Outcome; Vitamin B Complex	2013
Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report. BMC cancer, 2016, 07-07, Volume: 16 Topics: Aged; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Humans; Liver Neoplasms; Lung Neoplasms; Male; Mutation; Neoplasms, Multiple Primary; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins B-raf; Sorafenib; Treatment Outcome	2016
Painful Rashes on the Palms and Soles. Annals of the Academy of Medicine, Singapore, 2016, Volume: 45, Issue:10 Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Hand-Foot Syndrome; Humans; Liver Neoplasms; Male; Neoplasms, Multiple Primary; Niacinamide; Phenylurea Compounds; Sorafenib	2016